drugset / Trial / NCT01303328

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

NCT01303328 ↗

Phase 2 Completed 200 enrolled Mithra Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this phase-II study is to evaluate the efficacy and safety of an aqueous gel containing an antiviral, administered directly on cervix exhibiting high grade squamous or glandular intraepithelial lesion (CIN 2 and 3) in comparison with a placebo treatment.

Timeline

Start
2011-03
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject C1 Unknown — Other